Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Total Debt (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Total Debt for 16 consecutive years, with $35.9 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 2.94% to $35.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.9 million through Dec 2025, down 2.94% year-over-year, with the annual reading at $35.9 million for FY2025, 2.94% down from the prior year.
  • Total Debt for Q4 2025 was $35.9 million at Harvard Bioscience, up from $34.0 million in the prior quarter.
  • The five-year high for Total Debt was $49.3 million in Q3 2022, with the low at $34.0 million in Q3 2025.
  • Average Total Debt over 5 years is $41.1 million, with a median of $40.1 million recorded in 2023.
  • The sharpest move saw Total Debt grew 12.38% in 2022, then fell 21.91% in 2023.
  • Over 5 years, Total Debt stood at $48.3 million in 2021, then dropped by 3.12% to $46.8 million in 2022, then dropped by 21.91% to $36.6 million in 2023, then rose by 1.07% to $37.0 million in 2024, then decreased by 2.94% to $35.9 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $35.9 million, $34.0 million, and $34.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.